CTCBIO Inc. (KOSDAQ:060590)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,275.00
-45.00 (-1.36%)
At close: Jun 5, 2026
Market Cap78.30B -51.5%
Revenue (ttm)128.76B +6.1%
Net Income6.11B
EPS256.58
Shares Out 23.91M
PE Ratio12.74
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume48,019
Open3,295.00
Previous Close3,320.00
Day's Range3,230.00 - 3,350.00
52-Week Range3,230.00 - 7,680.00
Beta-0.04
Analystsn/a
Price Targetn/a
Earnings DateAug 21, 2026

About CTCBIO

CTCBIO Inc. provides various pharmaceutical products in South Korea and internationally. The company offers animal and human pharmaceuticals; feed additives and ingredients; and functional food products. It also provides cardiovascular, gastrointestinal, osteoporosis, antibiotic, smoking cessation, antifungal and antiviral, antiepileptic, allergic rhinitis, dermatology and genito-urinory, allergic rhinitis and antihistamine, neuropsychiarty, intestinal disorders, X-ray, diabetes, anti-inflammatory and arthritis, and harmones, as well as CTC cov... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1993
Employees 248
Stock Exchange KOSDAQ
Ticker Symbol 060590
Full Company Profile

Financial Performance

Financial Statements